参考文献/References:
[1] Chang JC,Wooten EC,Tsimelzon A,et al.Gene expression profiling for the prediction of therapeutic response to docetaxel inpatients with breast cancer.Lancet,2003,362(9381):362-369.
[2] 林其声,施雄文,徐书楷,等.新辅助化疗对乳腺癌ki-67、cox-2,p53表达的影响及其临床意义.中国当代医药,2009,16(24):13-14.
[3] McDermott GM,Welch A,Staff RT,et al.Monitoring primary breast cancer throughout chemotherapy using FDG-PET.Breast Cancer Res Treat,2007,102(1):75-84.
[4] Schwarz-Dose J,Untch M,Tiling R,et al.Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.J Clin Oncol,2009,27(4):535-541.
[5] 温广华,冯彦林,黄克敏,等.乳腺癌18F-FDG PET/CT标准化摄取值与Ki-67表达关系的初步研究.中国临床医学影像杂志,2010,21(7):509-511.
[6] 何仲琴,李恩孝.环氧化酶-2表达与肿瘤关系的研究进展.现代肿瘤医学,2005,13(4):573-575.
[7] Ruibal A,Abdulkader I,Gude F,et al.The immunohistochemical expression of cyclooxygenase 2 is inversely associated with 18F-FDG-PET SUV values in non-small-cell lung cancers.Initial results.Rev Esp Med Nucl,2009,28(1):11-14,
[8] Surowiak P,Materna V,Matkowski R,et al.Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance,Breast Cancer Res,2005,7(5):R862-R870.
[9] Denkert C,Winzer KJ,Hauptmann S.Prognostic impact of cyclooxygenase-2 in breast cancer.Clin Breast Cancer,2004,4(6):428-433.
[10] Zhao X,Goswami M,Pokhriyal N,et al.Cyclooxygenase-2 expression during immortalization and breast cancer progression.Cancer Res,2008,68(2):467-475.
相似文献/References:
[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[5]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[6]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[7]查金顺,蒋艳,徐源,等.131I辅以短期小剂量碳酸锂治疗Graves甲亢的研究[J].国际放射医学核医学杂志,2014,38(1):10.[doi:10.3760/cma.j.issn 1673-4114.2014.01.003]
Zha Jinshun,Jiang Yah,Xu Yuan,et al.Clinical research on radioiodine addition of low-doses of lithium carbonate in short-term treatment of Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):10.[doi:10.3760/cma.j.issn 1673-4114.2014.01.003]
[8]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[9]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[10]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[11]贾莉,邓智勇.乳腺癌新辅助化疗疗效评价的相关研究[J].国际放射医学核医学杂志,2013,37(4):239.[doi:10.3760/cma.j.issn.1673-4114.2013.04.012]
JIA Li,DENG Zhi-yong.Evaluation of response to neoadjuvant chemotherapy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):239.[doi:10.3760/cma.j.issn.1673-4114.2013.04.012]